Skip to main content
SpringerLink
Log in

CVD prevalence low in patients receiving ADHD medication

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. amphetamines, atomoxetine, dexmethylphenidate or methylphenidate

Reference

  • Fairman KA, et al. Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling? Drugs - Real World Outcomes : 5 Jan 2018. Available from: URL: https://doi.org/10.1007/s40801-017-0129-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CVD prevalence low in patients receiving ADHD medication. Reactions Weekly 1686, 10 (2018). https://doi.org/10.1007/s40278-018-41074-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41074-6

Search

Navigation